169 related articles for article (PubMed ID: 35562551)
1. Visual outcomes and predictors in optic pathway glioma: a single centre study.
Bowman R; Walters B; Smith V; Prise KL; Handley SE; Green K; Mankad K; O'Hare P; Dahl C; Jorgensen M; Opocher E; Hargrave D; Thompson DA
Eye (Lond); 2023 Apr; 37(6):1178-1183. PubMed ID: 35562551
[TBL] [Abstract][Full Text] [Related]
2. Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I.
Vagge A; Camicione P; Pellegrini M; Gatti G; Capris P; Severino M; Di Maita M; Panarello S; Traverso CE
Eur J Ophthalmol; 2021 Mar; 31(2):698-703. PubMed ID: 32066268
[TBL] [Abstract][Full Text] [Related]
3. Investigation of retinal nerve fiber layer thickness and ganglion cell layer-inner plexiform layer thickness in patients with optic pathway gliomas.
Hepokur M; Sarici AM
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1757-1765. PubMed ID: 29754292
[TBL] [Abstract][Full Text] [Related]
4. Correlation of peripapillary retinal nerve fibre layer thickness with visual acuity in paediatric patients affected by optic pathway glioma.
Parrozzani R; Miglionico G; Leonardi F; Pulze S; Trevisson E; Clementi M; Opocher E; Licata V; Viscardi E; Pilotto E; Frizziero L; Midena E
Acta Ophthalmol; 2018 Dec; 96(8):e1004-e1009. PubMed ID: 30284379
[TBL] [Abstract][Full Text] [Related]
5. Handheld optical coherence tomography during sedation in young children with optic pathway gliomas.
Avery RA; Hwang EI; Ishikawa H; Acosta MT; Hutcheson KA; Santos D; Zand DJ; Kilburn LB; Rosenbaum KN; Rood BR; Schuman JS; Packer RJ
JAMA Ophthalmol; 2014 Mar; 132(3):265-71. PubMed ID: 24435762
[TBL] [Abstract][Full Text] [Related]
6. The Relationship Between Choroidal Abnormalities and Visual Outcomes in Pediatric Patients With NF1-Associated Optic Pathway Gliomas.
Estrela T; Truong S; Garcia A; He J; Ying GS; Devakandan K; Reginald YA; Fisher MJ; Liu GT; Ullrich NJ; Avery RA; Heidary G
J Neuroophthalmol; 2024 Mar; 44(1):5-9. PubMed ID: 38252486
[TBL] [Abstract][Full Text] [Related]
7. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
Falzon K; Drimtzias E; Picton S; Simmons I
Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children].
Florent C; Beylerian M; Mairot K; Dambricourt L; André N; David T; Girard N; Audic F; Denis D
J Fr Ophtalmol; 2022 Feb; 45(2):173-184. PubMed ID: 34972579
[TBL] [Abstract][Full Text] [Related]
9. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
de Blank PM; Berman JI; Liu GT; Roberts TP; Fisher MJ
Neuro Oncol; 2013 Aug; 15(8):1088-95. PubMed ID: 23658320
[TBL] [Abstract][Full Text] [Related]
10. Measurements of Retinal Nerve Fiber Thickness and Ganglion Cell Complex in Neurofibromatosis Type 1, with and Without Optic Pathway Gliomas: A Case Series.
Sahinoglu-Keskek N; Altan-Yaycioglu R; Canan H; Coban-Karatas M; Erbay A; Yazıcı N; Alkan O
Curr Eye Res; 2018 Mar; 43(3):424-427. PubMed ID: 29185816
[TBL] [Abstract][Full Text] [Related]
11. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
Wolsey DH; Larson SA; Creel D; Hoffman R
J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
[TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomography versus visual evoked potentials in detecting subclinical visual impairment in multiple sclerosis.
Grecescu M
J Med Life; 2014; 7(4):538-41. PubMed ID: 25713617
[TBL] [Abstract][Full Text] [Related]
13. Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas.
Gu S; Glaug N; Cnaan A; Packer RJ; Avery RA
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1402-8. PubMed ID: 24519429
[TBL] [Abstract][Full Text] [Related]
14. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
Tekavčič Pompe M; Pečarič Meglič N; Šuštar Habjan M
Doc Ophthalmol; 2023 Apr; 146(2):121-136. PubMed ID: 36652041
[TBL] [Abstract][Full Text] [Related]
15. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Trimboli-Heidler C; Ishikawa H; Packer RJ; Linguraru MG
Neurology; 2016 Dec; 87(23):2403-2407. PubMed ID: 27815398
[TBL] [Abstract][Full Text] [Related]
16. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC
J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
[TBL] [Abstract][Full Text] [Related]
17. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.
Naismith RT; Tutlam NT; Xu J; Shepherd JB; Klawiter EC; Song SK; Cross AH
Neurology; 2009 Jul; 73(1):46-52. PubMed ID: 19564583
[TBL] [Abstract][Full Text] [Related]
18. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
[TBL] [Abstract][Full Text] [Related]
19. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
20. Retinal nerve fiber layer thickness in children with optic pathway gliomas.
Avery RA; Liu GT; Fisher MJ; Quinn GE; Belasco JB; Phillips PC; Maguire MG; Balcer LJ
Am J Ophthalmol; 2011 Mar; 151(3):542-9.e2. PubMed ID: 21232732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]